New consumer health company Kenvue explodes

Johnson & Johnson spin-off shares rocket 22% on stock exchange debut First GSK spun-off its consumer operation into Haleon, now Johnson & Johnson (J&J) has done the same with its consumer health division, now dubbed Kenvue, to resounding approval on the New York Stock Exchange (NYSE). The decision to spin-off the division, first announced in September 2021,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Consultants ‘a tough bunch,’ says winner
Next $5000 to become face of 60-day dispensing